Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
PRESSURE BIOSCIENCES INC (PBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2012 8-K Quarterly results
Docs: "Pressure BioSciences, Inc. Reports 2011 Financial Results Revenue Up 66% in Second Half Over First Half; Pace of Consumables Sales Increased Significantly in Second Half 2011"
11/17/2010 8-K Form 8-K - Current report
08/17/2010 8-K Form 8-K - Current report
05/18/2010 8-K Form 8-K - Current report
11/16/2009 8-K Quarterly results
Docs: "Pressure BioSciences, Inc. Announces Record Installations, Continued Improvements in Revenue & Cash Burn for Third Quarter 2009"
08/10/2009 8-K Form 8-K - Current report
05/05/2009 8-K Form 8-K -- Current report
03/31/2009 8-K Form 8-K -- Current report
03/04/2009 8-K Quarterly results
Docs: "Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008"
05/01/2008 8-K Quarterly results
Docs: "For the Three Months Ended March 31, 2008 2007 REVENUE: PCT Products, services, other $ 81,473 $ 37,943 Grant revenue 50,903 93,678 Total revenue 132,376 131,621 COSTS AND EXPENSES: Cost of PCT products and services 48,449 31,654 Research and development 490,931 461,532 Selling and marketing 463,161 256,530 General and administrative 501,248 481,082 Total operating costs and expenses 1,503,789 1,230,798 Operating loss from continuing operations OTHER INCOME: Realized gain on securities available for sale - 727,473 Interest income 30,308 71,602 Total other income 30,308 799,075 Loss before income taxes Income taxes from continuing operations - 40,519 Loss from continuing operations DISCONTINUED OPERATIONS: Loss on discontinued operations - Net loss $ $ Loss per share from continuing oper..."
03/12/2008 8-K Quarterly results
Docs: "Pressure BioSciences, Inc. 14 Norfolk Avenue, South Easton, MA 02375 TEL 508-230-1828 · FAX 508-230-1829 www.pressurebiosciences.com 2 Consolidated Balance Sheets December 31, ASSETS 2007 2006 CURRENT ASSETS Cash and cash equivalents $ 5,424,486 $ 5,335,282 Accounts receivable 118,471 37,495 Inventories 172,548 19,658 Deposits 553,483 175,300 Prepaid income taxes 56,863 38,687 Income tax receivable 249,541 710,013 Prepaid expenses and other current assets 94,783 71,476 Investments in marketable securities - 2,060,875 Total current assets 6,670,175 8,448,786 PROPERTY AND EQUIPMENT, NET 257,797 207,696 OTHER ASSETS Intangible assets, net 328,290 376,922 Assets of discontinued operation - 1,420,996 Total other assets 328,290 1,797,918 TOTAL ASSETS $ 7,256,262 $ 10,454,400 LIABILITIES AND STOC..."
11/13/2006 8-K Quarterly results
Docs: "Pressure BioSciences, Inc. Reports Third Quarter Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy